The Prophylactic Use of Topical Cyclosporine A 0.05% to Prevent Graft Versus Host Disease Related Dry Eye

Stopped early · Phase 4 · Has a placebo group

Conditions studied: Dry Eye

In brief

The purpose of this study is to determine whether Restasis is an effective treatment for preventing the occurrence and progression of dry eye syndrome in patients who have recently received a bone marrow transplant and are at risk to graft-versus-host disease.

Key facts

Study ID
NCT00553735
Run by
Massachusetts Eye and Ear Infirmary
People needed
8
Starts
2007-08-01
Expected to finish
2010-12-01
Last updated by the study team
2017-03-28

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.